Erlotinib Tablets I.p. 100 Mg About
Introducing ERLOTERO-100, the sought-after Erlotinib Tablets I.P. 100 mg by Mylan, perfect for those seeking a personalised approach in cancer care. This trending, prescription-only anticancer medicine is an ace EGFR inhibitor, designed specifically for adults battling non-small cell lung cancer and pancreatic cancer. Each lofty, film-coated tablet is available at a special price cut and comes with clear, bilingual labelling (English/Hindi). With each box containing 30 tablets, ERLOTERO-100 supports diverse treatment plans as prescribed by your physician. Exclusively made in India, it's a trusted and effective addition to therapy regimens.
Versatile Usage & Advanced Features of ERLOTERO-100
ERLOTERO-100 Erlotinib Tablets are administered orally and tailored for adults managing non-small cell lung cancer or pancreatic cancer. Their ace advantage lies in the film-coated design and measured 100 mg dosage, supporting precise personalisation as directed by a physician. Supplied in sealed boxes of 30 tablets with English and Hindi instructions, these trending tablets make cancer treatment accessible, reliable, and efficient. The shelf life and clear labelling further enhance the assurance for both patient and healthcare providers alike.
Swift Dispatch & Trusted Delivery Across Destinations
ERLOTERO-100 is available with stock ready for prompt dispatching, making sure patients get timely access to their medication. Freight options are flexible thanks to reliable FOB ports across major Indian hubs. Mylan upholds quality with all essential certifications, ensuring each batch meets stringent regulatory standards. With organised logistics and inventory, orders are efficiently processed and shipped, minimising delays and enhancing reliability for suppliers, traders, and healthcare institutions throughout India and abroad.
FAQ's of Erlotinib Tablets I.p. 100 Mg:
Q: How should ERLOTERO-100 Erlotinib Tablets be taken for best results?
A: ERLOTERO-100 tablets must be taken orally, strictly as directed by your physician. They should not be chewed or crushed, and are best taken on an empty stomach, at least one hour before or two hours after eating.
Q: What cancers are addressed by ERLOTERO-100 Erlotinib Tablets?
A: ERLOTERO-100 is mainly indicated for the treatment of non-small cell lung cancer and pancreatic cancer. Always consult your oncologist to determine suitability for your specific medical condition.
Q: When should I start treatment with ERLOTERO-100?
A: Initiation of treatment is determined by your treating specialist. Taking ERLOTERO-100 should begin only after a thorough discussion about your diagnosis and treatment plan as prescribed by your healthcare provider.
Q: Where is ERLOTERO-100 manufactured and can it be trusted?
A: ERLOTERO-100 is manufactured by Mylan in India, a renowned global pharmaceutical company. Each batch adheres to strict quality standards and is backed by the necessary certifications.
Q: What is the process for storing ERLOTERO-100 tablets safely?
A: Store ERLOTERO-100 tablets below 30C and keep them protected from moisture in their original box. Always check the expiry date on the pack and keep out of reach of children.
Q: How is ERLOTERO-100 beneficial for patients?
A: ERLOTERO-100 offers a personalised, targeted approach by inhibiting EGFR, a key factor in cancer cell proliferation, making it an effective solution for eligible patients, especially those with non-small cell lung or pancreatic cancer.